Persistence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor-positive (HR +) breast cancer

被引：0
|
作者：
Julia Foldi
Anastasia Tsagianni
Max Salganik
Catherine A. Schnabel
Adam Brufsky
G. J. van Londen
Lajos Pusztai
Tara Sanft
机构：
[1] Yale School of Medicine,Section of Medical Oncology
[2] University of Pittsburgh School of Medicine,Division of Hematology and Medical Oncology
[3] Biotheranostics Inc,undefined
[4] A Hologic Company,undefined
来源：
BMC Cancer | / 23卷
关键词：
Breast Cancer Index; Extended adjuvant endocrine therapy; Endocrine therapy adherence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Comparison of Adjuvant Radiation Therapy Alone Versus Radiation Therapy and Endocrine Therapy in Elderly Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Treated With Breast-Conserving Surgery
    Murphy, Colin T.
    Li, Tianyu
    Wang, Lora S.
    Obeid, Elias I.
    Bleicher, Richard J.
    Eastwick, Gary
    Johnson, Matthew E.
    Hayes, Shelly B.
    Weiss, Stephanie E.
    Anderson, Penny R.
    CLINICAL BREAST CANCER, 2015, 15 (05) : 381 - 389
  • [32] Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older women
    Carleton, Neil
    Nasrazadani, Azadeh
    Gade, Kristine
    Beriwal, Sushil
    Barry, Parul N.
    Brufsky, Adam M.
    Bhargava, Rohit
    Berg, Wendie A.
    Zuley, Margarita L.
    van Londen, G. J.
    Marroquin, Oscar C.
    Thull, Darcy L.
    Mai, Phuong L.
    Diego, Emilia J.
    Lotze, Michael T.
    Oesterreich, Steffi
    McAuliffe, Priscilla F.
    Lee, Adrian, V
    LANCET GLOBAL HEALTH, 2022, 3 (01): : E54 - E66
  • [33] Race differences in patient-reported symptoms and adherence to adjuvant endocrine therapy among women with early-stage, hormone receptor-positive breast cancer.
    Hu, Xin
    Walker, Mark S.
    Stepanski, Edward
    Kaplan, Cameron
    Martin, Michelle Y.
    Vidal, Gregory A.
    Schwartzberg, Lee S.
    Graetz, Ilana
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [34] Information needs of post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapy
    Feldman-Stewart, Deb
    Madarnas, Yolanda
    Mates, Mihaela
    Tong, Christine
    Grunfeld, Eva
    Verma, Shailendra
    Carolan, Hannah
    Brundage, Michael
    PATIENT EDUCATION AND COUNSELING, 2013, 93 (01) : 114 - 121
  • [35] What Is the Optimal Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive Early Breast Cancer?
    Tung, Nadine
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (11) : 1391 - 1397
  • [36] WinPro: A window of opportunity study of endocrine therapy with and without prometrium in postmenopausal women with early-stage hormone receptor-positive breast cancer
    Downton, Teesha
    Segara, Davendra
    Ong, Andrew
    Bingham, Janne
    Carson, Emma-Kate
    Chen, Julia
    Middleton, Kate
    Lindeman, Geoffrey
    Parker, Andrew
    Lim, Elgene
    CANCER RESEARCH, 2023, 83 (05)
  • [37] Nodal positivity decreases with age in women with early-stage, hormone receptor-positive breast cancer
    Downs-Canner, Stephanie M.
    Gaber, Charles E.
    Louie, Raphael J.
    Strassle, Paula D.
    Gallagher, Kristalyn K.
    Muss, Hyman B.
    Ollila, David W.
    CANCER, 2020, 126 (06) : 1193 - 1201
  • [38] Adjuvant Endocrine Therapy for Hormone Receptor-Positive Early Breast Cancer in Premenopausal Patient: Understanding the Data
    Saha P.
    Fleming G.F.
    Current Breast Cancer Reports, 2015, 7 (4) : 183 - 189
  • [39] The Role of Ovarian Suppression in Premenopausal Women With Hormone Receptor-Positive Early-Stage Breast Cancer
    Jain, Sarika
    Santa-Maria, Cesar Augusto
    Gradishar, William J.
    ONCOLOGY-NEW YORK, 2015, 29 (07): : 473 - +
  • [40] Delay Discounting and Adjuvant Endocrine Therapy Adherence in Hormone Receptor-Positive Breast Cancer
    Vaughn, Jennifer E.
    Ammerman, Chesley
    Lustberg, Maryam B.
    Bickel, Warren K.
    Stein, Jeffrey S.
    HEALTH PSYCHOLOGY, 2021, 40 (06) : 398 - 407
12345